Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Álvaro Torres De Rueda"'
Autor:
Pedro Rosa-Guerrero, Antonio Trujillo-Aguilera, Juan Molina, Ana Navas, Cristina López-Martín, Aurora Jurado, Alberto Rodríguez-Benot, Álvaro Torres-De-Rueda
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The impact of Covid-19 pneumonia caused by SARS-CoV-2 on transplanted populations under chronic immunosuppression seems to be greater than in normal population. Clinical management of the disease, particularly in those patients worsening after a cyto
Externí odkaz:
https://doaj.org/article/a1d055b1a8cc4ed89e904a3821e78f5d
Autor:
Cristina González Ruiz-Moyano, Claudia Muñoz Martínez, Álvaro Torres De Rueda, María Dolores Navarro Cabello, Alberto Rodríguez Benot, María Luisa Agüera Morales
Publikováno v:
Transplantation Proceedings. 54:2471-2474
Simultaneous pancreas-kidney (SPK) transplant is the primary option in patients with type 1 diabetes mellitus who develop end-stage kidney disease. Pancreas retransplant (PRt) has become an alternative in patients who experience pancreas graft failur
Autor:
Marta Ciudad Montejo, Álvaro Torres De Rueda, David A Rodríguez Fuentes, Maria Dolores Navarro Cabello, Alberto Rodríguez Benot, Rafael Santamaría Olmo, María Luisa Agüera Morales
Publikováno v:
Transplantation proceedings.
Living donor kidney transplant is the best treatment for end-stage kidney disease, posing minimal perioperative morbimortality for the donor, although long-term consequences are subject of debate if donor acceptance widens. We present a retrospective
Autor:
Pedro Rosa Guerrero, M. Luisa Agüera Morales, Álvaro Torres De Rueda, Alberto Rodriguez Benot, Claudia Muñoz Martínez, Magdalena Terán Redondo
Publikováno v:
Transplantation Proceedings
INTRODUCTION A large number de registries have been collected both kidney transplant recipients infected with COVID-19. MATERIALS AND METHODS From March 2020 to April 2021, our team conducted an observational study, which included all patients that s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261ac44e5dfbf2b93c17e52c3685bce5
https://hdl.handle.net/10668/22532
https://hdl.handle.net/10668/22532
Autor:
Guillermo, Martín-Reyes, Remedios, Toledo-Rojas, Álvaro, Torres-de Rueda, Eugenia, Sola-Moyano, Lourdes, Blanca-Martos, Laura, Fuentes-Sánchez, M Dolores, Martínez-Esteban, M José, Díez-de los Ríos, Alicia, Bailén-García, Miguel, González-Molina, Isabel, García-González
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 32(1)
Acute renal failure (ARF) occurs in 12%-20% of all multiple myeloma (MM) cases, and the survival of these patients depends on renal function recovery. Renal function is not recovered in 75% of dialysis-dependent patients, and their mean survival with
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.